Find a Press Release
Filter by title, related products, or keywords:
Norgen Biotek Offers First-Class Products to Assist Researchers in the Study and Molecular Diagnosis of the 2019 Novel Coronavirus (COVID-19) Outbreak
March 11, 2020THOROLD, ON, Feb. 18, 2020 /PRNewswire/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein stabilization and purification, today announced that they are offering a number of products to the scientific and medical community to support the study of the 2019 Novel Coronavirus (COVID-19, formerly 2019-nCoV) outbreak in humans.
Norgen Biotek's Cell-free DNA / Cell-free RNA (cf-DNA/cf-RNA) BCT Tube is Best-In-Class
February 12, 2019THOROLD, ON, Feb. 12, 2019 /PRNewswire/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein stabilization and purification, today announced their unique cf-DNA/cf-RNA Preservative Tubes were found to be the most suitable for liquid biopsy when compared to other leading competitor's blood collection tubes (BCTs).
Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing
November 20, 2018/PRNewswire/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider. Norgen's Propel Certification covers both the NextSeq 500 System and the NextSeq 550 System.
Diversigen and Norgen Biotek Partner to Offer End-to-end Solutions for Microbiome Sample and Analysis Research
July 10, 2018/PRNewswire/ - Diversigen Inc. (Houston, TX) and Norgen Biotek Corp. (Ontario, Canada) today announced that they have entered into a strategic partnership through which industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions to meet the growing needs for microbiome analyses.
Norgen Biotek Corp Launches New Portfolio for Next Generation Sequencing, including Library Preparation Kits and Full NGS Service Offering
July 12, 2017/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification and stabilization, today announced the recent launch of their new portfolio of product and service solutions for Next Generation Sequencing (NGS) applications. Norgen has extensive experience with NGS, and has leveraged this expertise to develop a number of new kits and workflows for NGS applications.
Norgen Biotek Corp. Announces Supply Agreement with Biodesix Enabling the First EML4-ALK Liquid Biopsy Test with Results in 72-Hours
March 2, 2016/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing on advancing powerful tools for DNA, RNA and protein stabilization and purification, today announced the signing of a supplier agreement with Biodesix, Inc. to supply novel sample preparation products based on Norgen Biotek’s proprietary purification technology. Biodesix, Inc.
Norgen Biotek Launches Novel Exosome Isolation and Exosomal microRNA Purification Kits
November 2, 2015/PRNewswire/ - Norgen Biotek, an innovative privately held Canadian biotechnology company focusing on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of novel kits for the fast and simple isolation of exosomes from plasma/serum, urine, and cell culture media. These novel kits are based on the use of Norgen’s proprietary resin to purify and concentrate the exosomes. These kits are simple, rapid and scalable. Furthermore, Norgen has developed kits for the isolation of high quality RNA from exosomes.
Norgen Biotek Corp Launches over 15 Novel Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma, Serum and Urine
September 28, 2015/CNW/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 15 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.
Norgen Biotek Corp (NBC) Launches 6 Novel Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma, Serum and Urine
June 4, 2014/CNW/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 6 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.
Norgen Biotek Corp. Achieves Accreditation to ISO 15189:2007 for Molecular Diagnostic Testing and Clinical Trials
October 5, 2011/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein preservation and purification from all type of specimens for research and molecular diagnostic applications, today announced successful accreditation to ISO 15189:2007 by the Standards Council of Canada (SCC). This ISO accreditation emphasizes our commitment to quality in our laboratory and R&D services.
Norgen Biotek to Develop Diagnostic Kits for use in Resource-Limited Areas
March 3, 2011/CNW/ - Norgen Biotek recently received a financial contribution of over $800,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). Norgen Biotek is an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification and preservation, as well as developing leading-edge diagnostic tools. This funding will allow Norgen to develop new point of care diagnostic technologies which are targeted for use in resource-limited settings.
Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
September 14, 2010Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products by launching 3 new urine concentration, preservation and isolation kits.
Norgen Biotek Transitions into Diagnostics with the Launch of over 30 New Kits for Nucleic Acid-Based Diagnostics
March 18, 2010Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Norgen makes best-in-class kits for NA and protein sample preparation, and has recognized that high quality sample preparation is the key to high quality diagnostics.
Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum
February 2, 2010Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 10 new kits for the fast and simple isolation of nucleic acids from blood, plasma and serum, including circulating nucleic acids. These kits provide fast, robust, reliable and simple procedures for isolating and purifying high quality macromolecules such as DNA, RNA, circulating NA and microRNA from a wide range of sample volumes (100 µL up to 10 mL).
Norgen Biotek Corp. Expands its Urine Sample Preparation Product Offering by Launching Novel Robust Urine DNA, RNA, microRNA, Proteins, Exfoliated Cells and Microorganisms Isolation Kits
January 6, 2010Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products.
Norgen Biotek Corp. Achieves ISO 13485:2003 and ISO 9001:2008 Certification
November 3, 2009/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein purification, today announced successful certification to ISO 13485:2003 and ISO 9001:2008. ISO 13485 and ISO 9001 are world-recognized quality management system standards, with ISO 13485 specifically pertaining to the requirements for a comprehensive management system for the design and manufacture of medical devices.
Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
March 17, 2009Norgen Biotek, an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids and protein purification, today announced the signing of an OEM agreement with Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) to supply RNA purification kits based on Norgen’s proprietary purification technology. Exiqon A/S is a Denmark-based company active in the life sciences, diagnostics and pharma services. Terms of the agreement were not disclosed.
High-quality DNA/RNA from Microorganisms in Environmental Samples
October 15, 2008/PRNewswire/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids and protein purification, today announced the launch of two new kits for the isolation of nucleic acids from environmental samples, the Soil DNA Isolation Kit and the Water RNA/DNA Purification Kit. These kits are ideal for environmental microbiological studies, and provide high quality, inhibitor-free DNA and/or RNA that can be used in various downstream applications such as PCR.
Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi
July 18, 2008/PRNewswire/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for RNA, DNA and protein purifications, today announced the expansion of its product offerings by launching four new kits geared towards the isolation of RNA and DNA from plants and fungi for research and diagnostic applications. In response to customer demands and emerging needs Norgen developed this new line of kits which are all available in spin-column formats as well as in 96-well plate formats for high throughput applications.
Norgen Biotek Corp. Launches FFPE RNA Purification Kit
April 22, 2008Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for RNA, DNA and protein purifications, today announced the expansion of its RNA product offerings by launching the FFPE RNA Purification Kit. In addition, Norgen is also offering a kit that recovers both RNA/DNA from FFPE archival samples, the FFPE RNA/DNA Purification Kit.
Norgen Biotek Corp. Launches the All-in-One Purification Kit for 4–in-1 Purification of RNA, microRNA, DNA and Proteins from a Single Sample
January 11, 2008Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification, today announced the expansion of its RNA product offerings by launching a powerful new tool for isolating RNA, microRNA, DNA, and proteins (the All-in-One Purification Kit) sequentially from a single sample. In addition, Norgen is also introducing their new Total RNA Purification 96-Well Kit for high throughput total RNA purification with the same benefits and features as our highly successful total RNA kit based on spin columns.
Norgen Biotek Corp Recognized as One of the Top 10 Life Sciences Companies in Canada
December 6, 2007/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification, today announced that it was recognized as one of Canada's Top 10 Life Science Companies. Canada's Top 10 Life Science Companies are evaluated by an independent international panel of life science venture capitalists. The panel selects companies based on their attractiveness as an exceptional investment in Canada, and Norgen Biotek was chosen as one of these companies.
Norgen Biotek Corp. Expands Novel Line of Urine-Based RNA, DNA and Protein Purification Kits
August 20, 2007Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification, today announced the expansion of its product offering by launching three new kits for the isolation of RNA and DNA from both the exfoliated cells and bacteria found in urine samples.
Norgen Biotek Corp. Launches 3–in-1 (RNA, DNA & Protein) Purification Kit from a single sample
January 9, 2007Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification, today announced the expansion of its product offering by launching a powerful tool for the isolation of RNA/DNA/Proteins (3 in 1 kit) sequentially from the same sample.
Norgen Biotek Corp. Launches A Novel Line of Kits for the Removal of Endotoxins From DNA, Peptides and Proteins
September 21, 2006Norgen Biotek, a product-focused and innovative Canadian biotechnology company dedicated to the development of powerful tools for nucleic acid and protein sample preparation, today announced the expansion of its nucleic acid and protein purification and clean up products by launching four new kits: the Endotoxin Removal Kits for DNA (mini and maxi formats) and the ProteoSpin™ Endotoxin Removal Kits for proteins and peptides (micro and maxi formats). These kits allow for the rapid removal of endotoxins from DNA, proteins and peptides very efficiently in three steps.
Norgen Biotek Corp. Expands its Product Line by Offering Three Novel DNA Isolation Kits
August 8, 2006Norgen Biotek, a product-focused and innovative Canadian biotechnology company dedicated to developing powerful tools for nucleic acid and protein purification, today announced the expansion of its nucleic acid line of purification products by launching three new kits: the Milk Bacterial DNA Isolation Kit, the Saliva DNA Isolation Kit, and the Urine Bacteria DNA Isolation Kit. Norgen's Saliva DNA Isolation Kit allows for the rapid isolation of high quality genomic DNA from up to 1 mL of saliva.
Norgen Biotek Corp. Expands its RNA Purification Product Line by Offering Novel RNA Isolation Kits
April 6, 2006Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful tools for nucleic acid and protein purification, today announced the expansion of its RNA isolation products by launching three new kits: Cytoplasmic and Nuclear RNA Purification Kit, Leukocyte RNA Purification Kit, and microRNA Purification Kit. These new kits, along with Norgen's Total RNA Purification Kit, are characterized by their simplicity and user friendliness. These kits make the purification of all types of RNA a simple and routine task.
Norgen Biotek Corp. Launches RNA Purification Kits
January 1, 2006Norgen Biotek Corp., a Canadian biotechnology company focusing principally on advancing powerful products for nucleic acids and protein purification, launched the first in its series of RNA purification products that are based on its patented purification technology.
Norgen Biotek Corp. Expands its DNA Purification Product Line by Offering a Novel Urine DNA Isolation Kit
October 25, 2005Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful tools for nucleic acid and protein purification, today announced the expansion of its nucleic acid line of products by launching four new kits: Urine DNA Isolation Kit, Low-Copy Plasmid MiniPrep Kit, BAC DNA MiniPrep Kit, and Bacterial Genomic DNA Isolation Kit. Norgen now offers nearly two dozen kits for genomics and proteomics research applications.
Norgen Biotek Corp. Expands ProteoSpin™ Product Line by Offering Rapid Urine Protein Concentration Kit, Generic Albumin Depletion Kit and On-Column Proteolytic Digestion Kit
June 27, 2005/CNW/ - Norgen Biotek Corp, an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein purification, today announced the expansion of the ProteoSpin(TM) line of products by launching three additional kits: the Urine Protein Concentration Kit, the Serum Albumin Depletion Kit, and the On-column Proteolytic Digestion Kit. These are now currently available under the ProteoSpin(TM) line of products.
Norgen Biotek Launches a Series of DNA, RNA and Protein Ladders
February 8, 2005Norgen Biotek Corp, an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein purification, today announced the launch and commercialization of DNA, RNA and genetically engineered Protein ladders. This is the second in a series of bio-consumable products launched by Norgen to meet the needs of scientists conducting research in genomics and proteomics.
Norgen Biotek selected as a Canadian Innovation Leader
October 3, 2003A St. Catharines, Ontario company is being recognized today as a national role model for innovation in Canada. Mr. Walt Lastewka, MP, on behalf of the Honourable Allan Rock, Minister of Industry and Minister responsible for the National Research Council (NRC), had high praise for Norgen Biotek, announcing that the firm was being acknowledged by NRC as one of Canada's Innovation Leaders.
.png)